ArticleFrontiers in medicine2025
Efficacy and safety of transumbilical laparoendoscopic single site surgery for mid-pregnancy ovarian cyst torsion: a retrospective analysis.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical and aesthetic outcomes of transumbilical single-port versus multi-port laparoscopic ovarian cystectomy.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the efficacy and safety of transumbilical laparoendoscopic single site surgery (TU-LESS) in treating mid-pregnancy ovarian cyst torsion. Methods: We conducted a retrospective analysis of the clinical data of 54 mid-pregnancy patients who underwent open surgery for ovarian cyst torsion repositioning and cystectomy, and 31 patients who underwent TU-LESS at Qinghai Red Cross Hospital between January 2020 and January 2025. Key parameters analyzed included operative time, intraoperative blood loss, postoperative complications, hospital stay, postoperative first flatus time, preoperative and postoperative fetal heart rates, pregnancy outcomes, and postoperative visual analog scale (VAS) pain scores. Results: There were no significant differences between the two groups in terms of baseline characteristics such as age, BMI, tumor diameter, number of deliveries, history of pelvic surgery, pregnancy duration, duration of abdominal pain, or preoperative fetal heart rate. The TU-LESS group had significantly shorter operative times compared to the laparotomy group. No significant differences were observed in tumor pathology, intraoperative blood loss, or number of tumor ruptures. The TU-LESS group experienced shorter hospital stays, fewer postoperative complications, and lower VAS scores at 48 h post-operation compared to the laparotomy group. However, there were no significant differences between the groups in terms of time to first flatus, postoperative fetal heart rates, and VAS scores at 24 h post-operation. Conclusion: TU-LESS is a safe and feasible surgical method for treating mid-pregnancy ovarian cyst torsion and plays an important role in protecting maternal and fetal safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.